Diana, It is hard to give a definitive answer to your question ". do I even need to compensate PE v. APC? Obviously I can't do the biexponential transformation if I don't, but what are the rules about compensating channels with little or no spectral overlap? " Most likely the answer is Yes. There appear to be some confusion here. First, biexponential plots are not just to be used on compensated data. They are useful for all data. The reason people connect them with compensation is that biexponential plots easily reveal poorly compensated data (as it does in your lower right hand plot). They won't necessarily tell you why the compensation is off. As to when to compensate, the best and safest answer is "always and for all channels". Differences of as little as 0.5% can significantly affect the data for dyes with 1-2% spillovers. You don't mention the spillover values for your expt so it's not easy to judge what going on in your situation. Given your graphs I suspect that one problem you have had in setting your comps is in your gating of the "lymphocyte" population. A key rule for accurately setting compensation (even more important for low spillovers) is that the background/autofluorescence of the negative cells MUST be equal to the background/autofluorescence of the positive cells. Your positive cells are a clean population of CD8+ lymphocytes. I'm not so sure your "negatives" are only lymphocytes. It looks as if your "lymphocyte" population also include some monocytes. These will be included in the negative population and will adversely affect your compensation. That is why many people use Ig-capture beads to perform compensations. This problem is avoided. (Disclaimer: BDB sells such Ig-capture beads, but that is not my reason for the recommendation). If you still want to use stained samples, put a much tighter gate around the lymphocytes. It really doesn't matter if 50% of the lymphocytes are gated out. Its more important to exclude all other types of cells. A second potential problem which you note is that the comp control was a week old fixed sample. A second key rule for compensation is that the fluorescence spectrum of the Comp control fluorophore must match the fluorescence spectrum of the reagent being comped. Normally I would not expect the spectrum of FITC to change over time but the same may not be true for APC. APC is a multimeric protein which can breakdown over time affecting the fluorescence emission spectrum. And you are correct, small differences in spectral emission (not intensity) can have a big effect on the perceived spillover especially on low spillovers. With the right controls compensation really is fairly straight-forward. On digital instruments it's a simple mathematical calculation. Good luck, Alan Stall BD Biosciences ============================================== Diana Martin <zigra@uga.edu> 10/07/05 07:56 AM To: Cytometry Mailing List <cytometry@flowcyt.cyto.purdue.edu> cc: (bcc: Alan Stall/SDCA/BDX) Subject: More on the mysterious case of the biexponential transformation... Flowers, I've had time to go back and look at this data again. I've included my comp controls and what to (my) naked eye looks like a bright enough PE comp control is not, in fact, true. The MFI (median) of the PE+ comp control is 1059, for the sample it is 1267. I used CD8 PE for both samples, but the comp control was about a week old (fixed mouse SC). We have been doing this pretty regularly the past year, but apparently a small loss of fluorescence over time, or differences in day to day staining, can make a big difference. I've included a graph with: Top = lymphocyte gate Middle = PE single stain (left), APC single stain (right) Bottom = CD8 PE v. IFNg APC left = uncompensated, right = compensated So my next question... do I even need to compensate PE v. APC? Obviously I can't do the biexponential transformation if I don't, but what are the rules about compensating channels with little or no spectral overlap? Thanks for everyone's comments. Diana Diana L. Martin Post-Doctoral Fellow Center for Tropical and Emerging Global Diseases University of Georgia Athens, GA 30602 (706)542-3396 This attachment - 'IC stain.jpg' - 357.04 KBytes - can be viewed at http://www.cyto.purdue.edu/MD-parts/29147e1f6be05cf6678981feeb4580106a11a184.jpg ----------------------------------------- ************************************************** IMPORTANT MESSAGE FOR RECIPIENTS IN THE U.S.A: This message may constitute an advertisement of BD group's products or services or a solicitation of interest in them. If this is such a message and you would like to opt out of receiving future advertisements or solicitations from this BD group, please forward this e-mail to the optoutbygroup@bd.com. ************************************************** This message (which includes any attachments) is intended only for the designated recipient(s). It may contain confidential or proprietary information and may be subject to attorney-client privilege or other confidentiality protections. If you are not a designated recipient, you may not review, use, copy or distribute this message. If you receive this is in error, please notify the sender by reply e-mail and delete this message. Thank You ************************************************** Corporate Headquarters Mailing Address: BD (Becton, Dickinson and Company) 1 Becton Drive Franklin Lakes, NJ 07417 U.S.A.Received on Tue Oct 11 17:18:00 2005
This archive was generated by hypermail 2.1.8 : Sat Jan 14 2006 - 22:03:55 EST